|
|
|
Biological Activity:
Protein kinase inhibitor, targeting Bcr-Abl/c-kit/PDGF-R.
References: online 1
M Deininger and BJ Druker. Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib. Pharmacol. Rev. 2003,55: 401-423.
TS May. Gleevec: tailoring to fit. Drug Disc. Today (DDT), 2003, 8 (5), 188-189. [online]
Chemical Name:
|
| Imatinib | Bcr-Abl inhibitor | Axon Medchem | Axon 1394 | CGP 57148B - STI 571 - Gleevec - Glevic |
|
Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.
axonmedchem.com © 2011 |
![]() |
Axon Ligands In The Field:
AZD 0530 | Src-Abl inhibitor
Dasatinib | Bcr-Abl/Src inhibitor
Nilotinib | BCR-ABL inhibitor
PD 180970 | BCR-ABL inhibitor
SKI 606 /Bosutinib | ABL/Src inhibitor
SU 6656 | Src Kinase Inhibitor
Click To See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection |